Purchase Order HHSN261201800234P

<p>The National Cancer Institute awarded a purchase order to Tecan U.S., Inc. for $7,878.00 on March 8, 2018, with an ultimate completion date of March 7, 2019. The order is fixed-price with economic price adjustment and carries no set-aside. Work is performed in Bethesda, Maryland. The purchase order covers laboratory automation equipment or related maintenance services typical of Tecan's OEM product line, delivered to the National Cancer Institute's facilities.</p>

<p>The National Cancer Institute issued a purchase order to Tecan U.S., Inc. on August 16, 2016, valued at $3,604.93 for firm fixed price, with an ultimate completion date of May 23, 2021. The order represents a de-obligation of funds from expiring FY2016 lines with no set-aside. Place of performance is Bethesda, Maryland.</p>

<p>The National Cancer Institute awarded a purchase order to Menarini Silicon Biosystems, Inc. for $18,700.00 on August 24, 2017. Performance takes place in Bethesda, Maryland. The order carries a firm fixed price and was due for completion by January 27, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $7,821.75 on March 14, 2019, with an ultimate completion date of March 14, 2020. The order is firm fixed price with no set-aside designation. Place of performance is Gaithersburg, Maryland. The purchase order was issued to de-obligate funds from FY2019 expiring lines in accordance with NIH Office of Administrative Law and Management communication.</p>

<p>The National Cancer Institute awarded a purchase order to Thomas Scientific, LLC for $11,426.73, with an award date of February 15, 2018 and ultimate completion date of March 15, 2018. No set-aside was used. The order covers laboratory supplies and equipment, with place of performance at Bethesda, Maryland. Pricing is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $4,470.04 on April 6, 2018, with completion on June 22, 2019. Work was performed in Bethesda, Maryland. The order carried firm fixed price and no set-aside designation. The source does not specify the items or services procured.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Thomas Scientific, LLC for $10,484.54 on June 26, 2018. Place of performance is Bethesda, Maryland. The ultimate completion date is July 26, 2018. No set-aside applies. The order procures laboratory supplies and equipment, consistent with the vendor's primary business of distributing consumable and durable medical laboratory goods to federal agencies.</p>

<p>The National Cancer Institute issued a purchase order to Tecan U.S., Inc. valued at $4,793.91, awarded August 24, 2017, with an ultimate completion date of October 30, 2017. The order is for Tecan and lab supplies, to be performed in Morrisville, North Carolina. Pricing is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $14,797.00 on September 8, 2017, with ultimate completion on September 7, 2018. Performance occurs in Bethesda, Maryland. The order is fixed-price with economic price adjustment and carries no small business set-aside. The source does not specify the particular equipment, software, or services procured under this order.</p>